Today: 11 June 2026
Bank of America stock today: BAC slips after $1B staff share award as rate-cap worries swirl
20 January 2026
2 mins read

Bank of America stock today: BAC slips after $1B staff share award as rate-cap worries swirl

New York, Jan 20, 2026, 11:45 EST — Regular session

  • Shares of Bank of America slipped roughly 0.3% during late-morning trading.
  • The bank announced plans to grant roughly $1 billion in equity to its non-executive staff.
  • U.S. bank stocks remained under pressure as investors awaited clarity on the proposed credit-card rate cap.

Bank of America Corporation shares slipped 0.3% to $52.83 on Tuesday following the announcement that it will grant roughly $1 billion in stock to employees outside senior management. CEO Brian Moynihan said, “when our teammates share in our company’s success, it strengthens our business and the communities we serve.” The bank said the awards represent nearly 19 million shares and will be distributed to about 96% of its workforce, continuing the program for the ninth consecutive year. PR Newswire

The grant doesn’t hit the balance sheet, but it does increase the share count, albeit slightly. This comes at a time when investors are on edge about costs, consumer credit, and anything that might squeeze earnings power.

The timing coincides with a looming policy risk. U.S. bank stocks dropped as investors eyed the Trump administration’s Jan. 20 deadline to enforce a 10% cap on credit-card interest rates. JPMorgan slipped 1.8%, Citigroup fell 2.4% in morning trading, per Reuters. “For now, it’s an overhang, but that overhang could clear quickly,” said Brian Jacobsen, chief economic strategist at Annex Wealth Management, noting Congress might ultimately decide the outcome. Analysts at TD Cowen see “a political compromise” emerging. Reuters

Bank of America has taken advantage of a stronger mood in capital markets. According to Reuters, the bank exceeded fourth-quarter profit expectations last week and reported its 2025 profit climbed to $30.5 billion, up from $27 billion the previous year. Its shares finished 2025 roughly 25% higher, marking a third consecutive year of gains.

The sector’s focus remains split between earnings and rates. U.S. Bancorp posted a nearly 23% rise in quarterly profit, driven by higher interest income and increased fee revenue. CEO Gunjan Kedia highlighted “record consumer deposits” and strategic balance-sheet moves. Net interest income—the gap between loan earnings and deposit costs—increased 3.3% to $4.28 billion, according to Reuters. Reuters

Bank of America’s use of employee stock awards is nothing new, but investors typically boil it down to two key concerns: how lean management intends to keep expenses and whether the bank will keep share issuance under control.

Washington could prove to be the bigger wildcard for major consumer banks. Should a strict cap on card rates take hold, banks might pull back on credit, slash rewards, or rearrange fees. Such shifts could curb spending and slow loan growth, even as they help safeguard profit margins.

Rates remain a key factor. But as investors wrestle with bank earnings in a lower-rate environment, loan demand and deposit costs take on greater importance.

Traders are eyeing the Federal Reserve’s policy meeting on Jan. 27-28 for clues on interest rate moves. Before that, they’ll look for clear guidance from the White House or Congress about what comes after the Jan. 20 credit-card deadline.

Stock Market Today

  • Johnson Controls International (JCI) Valuation Review Amid Recent Share Decline
    June 11, 2026, 10:52 AM EDT. Johnson Controls International (NYSE:JCI) shares fell 5.7% recently, despite solid annual revenue of US$24.4 billion and net income of US$2 billion. The stock trades slightly above its fair value estimate of US$138.11, which factors in a 9.38% discount rate and modest revenue growth forecast of 5.56%. Analyst models reflect steadier revenue expansion and improved profit margins, yet caution remains due to potential operational disruptions from a new segment structure and execution risks related to cost-saving initiatives. Investors are urged to evaluate both risks and rewards amid the short-term price weakness and maintain a close watch on ongoing financial performance and strategic execution.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB
Previous Story

Grab stock rises even as Wall Street slides after BofA upgrade — what’s next for GRAB

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Next Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

Go toTop